Crossmark

Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

Published Print: 2024-01

Authors

Gratacós-Masmitja, Jordi

Beltrán Catalán, Emma

Álvarez Vega, José Luis

Urruticoechea-Arana, Ana

Fito, Concepción

Maceiras, Francisco

Belzunegui Otano, Joaquín María

Fernández Melón, Julia

Chamizo Carmona, Eugenio

Abad Hernández, Miguel Ángel

Ros Vilamajó, Inmaculada

Castro Oreiro, Sonia

Pascual Alfonso, Eva

Torre Alonso, Juan Carlos
Funding

Funding for this research was provided by:

Celgene

AbbVie
License Information

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2023-08-09
More Information

This article is maintained by: Elsevier

Article Title: Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2023.06.007

Content Type: article

Copyright: © 2023 The Authors. Published by Elsevier España, S.L.U.

Document is current